Company / Operating Cash Flow
Traws Pharma, Inc. Operating Cash Flow History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$29.8M
FY2024
5-year range
-$29.8M / -$16.3M
FY2020-FY2024
Trend
-82.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$58M in FY2015 to -$16M in FY2017.
Based on SEC 10-K filings.
-$30M in FY2024.
Declined from -$19M to -$30M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow decreased 82.8% year-over-year.
- Peak operating cash flow was recorded in FY2017.
- Lowest operating cash flow in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$29.8M | -82.8% |
| FY2023 | -$16.3M | +16.4% |
| FY2022 | -$19.5M | +15.5% |
| FY2021 | -$23.1M | -10.8% |
| FY2020 | -$20.8M | +8.2% |
| FY2019 | -$22.7M | +4.7% |
| FY2018 | -$23.8M | -50.6% |
| FY2017 | -$15.8M | +49.4% |
| FY2016 | -$31.2M | +45.8% |
| FY2015 | -$57.6M | -3630.2% |
As of FY2024 · SEC 10-K Annual Filings · Last checked Jun 28, 2026